2 results found for: “rinvoq”.

Request time (Page generated in 0.2702 seconds.)

Upadacitinib

Upadacitinib, sold under the brand name Rinvoq, is a Janus kinase (JAK) inhibitor medication for the treatment of moderately to severely active rheumatoid...

Last Update: 2020-12-26T23:26:32Z Word Count : 3057 Synonim Upadacitinib

Janus kinase inhibitor

thrombocythemia. Approved by U.S. FDA on 16 August 2019. Upadacitinib (trade name Rinvoq; ABT-494) against JAK1 for rheumatoid arthritis. Approved by U.S FDA on...

Last Update: 2021-04-12T21:44:28Z Word Count : 1911 Synonim Janus kinase inhibitor

Main result

Upadacitinib

Upadacitinib, sold under the brand name Rinvoq, is a Janus kinase (JAK) inhibitor medication for the treatment of moderately to severely active rheumatoid arthritis in adults where methotrexate (a drug used to treat active arthritis) did not work well or could not be tolerated. It was approved for medical use in the United States and in the European Union in 2019, and was developed by the biotech company AbbVie. Common side effects include upper respiratory tract infections (common cold, sinus infections), nausea, cough, and fever.Upadacitinib works by blocking the action of enzymes called Janus kinases. These enzymes are involved in setting up processes that lead to inflammation, and blocking their effect brings inflammation in the joints under control.


rinvoq
Synonim i słownik wyrazów